{"title":"Transcatheter aortic valve implantation—2014 update","authors":"E. H. Q. Phang, E. Tay, J. Hon","doi":"10.1002/cce2.5","DOIUrl":"https://doi.org/10.1002/cce2.5","url":null,"abstract":"There is a growing trend for high‐risk patients with severe aortic stenosis who are denied open heart surgery to undergo transcatheter aortic valve implantation (TAVI). Since its invention more than two decades ago, TAVI has evolved rapidly from the proof‐of‐concept phase to become an established Food and Drug Administration‐approved technology. This article reviews the developmental histories and current status, as well as the future advancement of the technique.","PeriodicalId":100331,"journal":{"name":"Continuing Cardiology Education","volume":"6 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2015-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"82519698","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Rationale and indications for coronary chronic total occlusion interventions","authors":"M. Vo, S. Rinfret","doi":"10.1002/cce2.2","DOIUrl":"https://doi.org/10.1002/cce2.2","url":null,"abstract":"Chronic total occlusions (CTOs) are commonly found in patients with coronary artery disease and are considered the “final frontier” of coronary intervention. Despite growing interest in percutaneous coronary intervention (PCI) of CTOs along with advances in techniques and equipment, attempt rates remain low. This is most likely due to the fact that CTO PCI remains technically challenging and requires higher resource utilization. Furthermore, there remains controversy regarding the actual clinical benefit of successful CTO PCI. However, there have been a growing number of studies reporting short‐ and long‐term outcomes of CTO revascularization. We therefore sought to review the evidence and potential clinical benefits of successful CTO PCI.","PeriodicalId":100331,"journal":{"name":"Continuing Cardiology Education","volume":"10 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2015-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"83285595","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"From research to education: shift of paradigm","authors":"R. Griebenow","doi":"10.1002/CCE2.13","DOIUrl":"https://doi.org/10.1002/CCE2.13","url":null,"abstract":"Continuing medical education (CME), as part of continuing professional development (CPD), is a cornerstone of specialist medical practice. Cardiology has been facing huge progress over the last three decades, making education as a means to disseminate innovations as well as guideline recommendations an invaluable tool in maintaining medical competence. During the past decades, the number of specialist journals has probably increased in nearly every country, but most of them address mainly publication of original papers presenting results of scientific research. Only few have a primary focus on education. Thus, it is highly welcome that a new Journal has been launched which is entirely devoted to continuing education in cardiology. What is the profile of this new Journal? ● It is a purely electronic and freely available online journal, offering global and “barrier-free” access to education in cardiology. ● It is entirely devoted to education, offering: o Independent (all articles have to be accredited by EBAC, the European Board for Accreditation in Cardiology, the journal has no ads) o Comprehensive (all authors are granted free of charge access to the Cochrane Library by EBAC) o And balanced information (all authors will be selected on basis of their clinical expertise).","PeriodicalId":100331,"journal":{"name":"Continuing Cardiology Education","volume":"1 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2015-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"84383578","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
I. Ungi, P. Tajti, P. Hausinger, A. Katona, V. Sasi, A. Thury
{"title":"The retrograde approach to coronary chronic total occlusion interventions","authors":"I. Ungi, P. Tajti, P. Hausinger, A. Katona, V. Sasi, A. Thury","doi":"10.1002/cce2.3","DOIUrl":"https://doi.org/10.1002/cce2.3","url":null,"abstract":"The results of percutaneous coronary interventions (PCI) dramatically improved in the last decades. Despite this improvement chronic total coronary occlusions (CTO) still remain a major challenge of interventional cardiology due to the complexity of these lesions. Retrograde recanalization proved to be one of the most significant amendments of the technique. Careful assessment of the occluded vessel, the donor artery and the interventional collaterals has fundamental importance for a safe and efficient procedure. High‐quality diagnostic angiogram and other imaging methods also have paramount importance for the success. The proper selection of the vascular access for retrograde CTO PCI can be challenging in patients with peripheral artery disease because of special requirements toward the guiding catheters. The latest publications demonstrated continuous improvement in the results together with decreasing complication rates of retrograde procedures. This technique significantly increased the number of patients who can be treated with PCI even with failed previous antegrade attempt.","PeriodicalId":100331,"journal":{"name":"Continuing Cardiology Education","volume":"23 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2015-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"83424156","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Hybrid approach to treatment of atrial fibrillation","authors":"C. Ong, T. Kofidis","doi":"10.1002/cce2.4","DOIUrl":"https://doi.org/10.1002/cce2.4","url":null,"abstract":"Atrial fibrillation (AF) is the most common sustained arrhythmia encountered in clinical practice. For years, there has been much interest and much is written with regard to the integrated or hybrid multidisciplinary approach toward cardiovascular care. The hybrid approach has been established in many centers, mostly with respect to ischemic heart disease. However, it is only a new and upcoming trend toward the use of a hybrid approach to treating cardiac arrhythmias. This hybrid approach to treating AF, while not the prevalent practice, is supported by medical literature. This review article examines the hybrid approach to treatment of AF, its benefits, disadvantages, and safety, as well as the long‐term results, based on current available literature. The hybrid approach to treatment of AF, combining surgical epicardial, and catheter endocardial ablation, showed a higher success rate compared to either technique alone. The increasing cooperation and professional intimacy between cardiologists and cardiothoracic surgeons are likely to continue and the hybrid approach, with its benefits while bearing in mind its limitations, may become the gold standard for treatment of drug‐resistant AF for the coming decade and beyond.","PeriodicalId":100331,"journal":{"name":"Continuing Cardiology Education","volume":"27 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2015-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"74761831","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
求助内容：
应助结果提醒方式：
京公网安备 11010802042870号
